Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Microscopic polyangiitis].

J P Venetz1, J Rossert

  • 1Service de Néphrologie B et INSERM U489, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris et Université Paris VI, 4, rue de la Chine, 75020 Paris, France.

Annales De Medecine Interne
|July 18, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of Intraoperative Duplex Ultrasound and Resistance Index Reduces Complications in Living Renal Donor Transplantation.

Transplantation proceedings·2018
Same author

Giant warts in a kidney transplant patient: regression with sirolimus.

The British journal of dermatology·2010
Same author

Population pharmacokinetics of ganciclovir in solid-organ transplant recipients receiving oral valganciclovir.

Antimicrobial agents and chemotherapy·2009
Same author

Disposition of valganciclovir during continuous renal replacement therapy in two lung transplant recipients.

The Journal of antimicrobial chemotherapy·2008
Same author

Primary glomerulonephritis: an update on renal survival and determinants of progression.

QJM : monthly journal of the Association of Physicians·2008
Same author

New insight into solvent-related end-stage renal disease: occupations, products and types of solvents at risk.

Occupational and environmental medicine·2007
Same journal

[Consensus Development Conference on Thrombosis and Pregnancy. 14 March 2003, Paris, France. Proceedings].

Annales de medecine interne·2004
Same journal

Kartagener's syndrome and renal failure.

Annales de medecine interne·2004
Same journal

Inflammatory pseudotumor of lymph nodes.

Annales de medecine interne·2004
Same journal

[Necrolytic migratory erythema revealing glucagonoma without diabetes].

Annales de medecine interne·2004
Same journal

[Bilateral primary non-Hodgkin's lymphomas of the adrenals].

Annales de medecine interne·2004
Same journal

[Acute "pseudo-angiocholitis" due to colonic adenocarcinoma in a man with primary sclerosis cholangitis and ulcerative colitis].

Annales de medecine interne·2004
See all related articles

Microscopic polyangiitis is a small vessel vasculitis often causing severe glomerulonephritis. Diagnosis relies on biopsy and anti-neutrophil cytoplasmic antibodies (ANCA), with treatment achieving high remission rates.

Area of Science:

  • Nephrology
  • Rheumatology
  • Immunology

Context:

  • Microscopic polyangiitis (MPA) is a non-granulomatous necrotizing vasculitis affecting small blood vessels.
  • Rapidly progressive glomerulonephritis is a common and severe manifestation of MPA.
  • Diagnosis requires organ biopsy and detection of anti-neutrophil cytoplasmic antibodies (ANCA).

Purpose:

  • To outline the diagnostic criteria and treatment strategies for microscopic polyangiitis.
  • To highlight the role of ANCA testing in diagnosing MPA and related vasculitides.
  • To discuss treatment outcomes, including remission rates and potential for relapse.

Summary:

  • MPA presents with diverse clinical features, notably severe glomerulonephritis.
  • Diagnostic hallmarks include necrotizing vasculitis on biopsy and specific ANCA positivity (targeting myeloperoxidase or proteinase 3).

Related Experiment Videos

  • Treatment for severe MPA involves corticosteroids and cyclophosphamide, achieving >90% remission, though relapses occur in ~30%.

    • Impact:

    • Establishes diagnostic standards for microscopic polyangiitis.
    • Provides evidence-based treatment guidelines for MPA management.
    • Informs prognosis and long-term patient monitoring, especially for renal function preservation.